ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk Of Surgical Infection, New Study Finds
New polymer material designed to
stop bone bleeding in surgery reduces the risk of surgical infection,
according to a new animal study to be published in the February 2008 issue
of Clinical Orthopaedics and Related Research (CORR). The study has
implications for lowering the risk of hospital-acquired infections,
including MRSA.
Researchers from the Medical University of South Carolina at Charleston
and Keck School of Medicine at the University of Southern California in Los
Angeles compared newly available polymer, Ostene(R), with bone wax,
traditionally used to stop bone bleeding in surgically cut bone surfaces.
The scientists looked at the two materials' effect on bone infection in the
presence of Staphylococcus Aureus, similar to the organism that is
responsible for MRSA. The results showed that, when exposed to bacteria,
the bones treated with Ostene(R) were four times less likely to get
infected than the bones treated with bone wax, 100% of which developed
infection. The study also showed that the bones treated with Ostene(R)
healed normally, while the presence of bone wax inhibited bone growth.
Bone wax, a beeswax-based product, is the least expensive and most
commonly used bone hemostasis material despite its well-documented side
effects: Numerous studies indicate that bone wax interferes with the body's
ability to clear bacteria and increases the risk of hospital-acquired
infections; it is also known to inhibit bone growth and bone healing after
surgery.
Ostene(R) offers an alternative that does not increase the risk to
patient. Its use in place of bone wax may help reduce serious
post-operative complications, including sternal wound infection and the
separation of the sternum. The material is used in cardiac, orthopedic,
oral, and neurosurgery. Other applications under development include the
use of Ostene(R) as a safe, soluble delivery vehicle for a variety of
therapeutic agents, from antibiotics to bone growth factors. Ostene(R) is
authorized for sale both in the U.S. and the European market.
Ostene(R) is a sterile mixture of water-soluble alkylene oxide
copolymers developed as an affordable, easy-to-handle synthetic bone
hemostasis material that reduces the overall risk of post surgical
infections, sternal non-union, poor bone healing and chronic inflammation.
Wax-like and malleable during application, the biomaterial dissolves
rapidly and is eliminated from the body shortly after surgery. The
material's main polymer component inherently reduces bacterial adhesion.
Ostene(R) is the only available product designed to stop bone bleeding in
surgery that does not interfere with bone healing or add the risk of
surgical infections, including MRSA.
The results of the USC/MUSC study suggest that the use of Ostene(R) may
have implications for reducing the risk of surgical site infection and for
improving post-operative healing and recovery. The benefits of Ostene(R)
may be particularly significant in lowering the rates of serious
complications following cardiac surgery, especially among a growing
high-risk group of diabetic and overweight patients, who currently
represent at least 25% of the 640,000 open heart surgery procedures
performed each year in the US.
"Ostene(R)'s unique properties are particularly significant now that we
are battling the threat of hospital-acquired infections, especially MRSA,"
Ceremed's president and CEO Tadeusz Wellisz, M.D., commented on the study.
"Ceremed is currently developing the next generation of Ostene(R) with
antibiotics, specifically designed to prevent hospital-acquired surgical
infection."
About The Company:
Ceremed, Inc. is a privately held medical device corporation formed in
2002 by a surgeon and a group of scientists from the University of Southern
California. The company has unique expertise and a portfolio of innovative
proprietary technology in the field of soluble alkylene oxide copolymers.
These polymers have multiple medical applications, including bone
hemostasis and a delivery system for a variety of therapeutic agents.
Ceremed, Inc.
http://www.ceremed.com
Ceremed lui OSTENE (R) opreºte osoase, sângerãri fãrã adaos de risc de infecþie chirurgicale, nou studiu constatã - Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk Of Surgical Infection, New Study Finds - articole medicale engleza - startsanatate